Sunlenca (lenacapavir)

lenacapavir · Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sunlenca (lenacapavir), covering 2025-06-19 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: CAbotégravir LENacapavir DUal Long Acting [Phase 2]